4.5 Article

Comparison of MAFLD and NAFLD Characteristics in Children

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Ramy Younes et al.

Summary: Lean Caucasian subjects with NAFLD may progress to advanced liver disease, develop metabolic comorbidities, and experience cardiovascular disease and liver-related mortality, independent of longitudinal progression to obesity and PNPLA3 genotype. These patients represent one end of a wide spectrum of phenotypic expression of NAFLD.
Review Medicine, Research & Experimental

Recent advances in lean NAFLD

Ruohui Xu et al.

Summary: As the most common type of chronic liver disease, nonalcoholic fatty liver disease (NAFLD) has become a global concern. Approximately 10-20% of individuals with NAFLD who are not overweight or obese have lean NAFLD. Lean individuals with NAFLD have a lower prevalence of certain health conditions but higher fibrosis scores and rates of cardiovascular morbidity and all-cause mortality in advanced stages. The pathophysiological mechanisms of lean NAFLD remain poorly understood, with factors such as environmental, genetic susceptibility, and epigenetic regulation being correlated. This review aims to explore the research progress and characteristics of lean NAFLD and investigate the role of epigenetic modification for clinical treatment and diagnosis.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Gastroenterology & Hepatology

Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents

Stefano Ciardullo et al.

Summary: This study aimed to evaluate the prevalence of MAFLD among US adolescents and investigate whether the new MAFLD definition can identify individuals with more advanced liver disease. The study found that most US adolescents with elastographic evidence of steatosis meet the criteria for MAFLD, but these criteria do not appear to improve the detection of subjects with more advanced liver disease.

HEPATOLOGY COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017-2018 National Health and Nutrition Examination Survey

Stefano Ciardullo et al.

Summary: The prevalence of MAFLD and significant fibrosis is alarmingly high among adolescents in the National Health and Nutrition Examination Survey 2017-2018. Factors such as body mass index, sex, ethnicity, and hypertension are associated with steatosis, while factors like body mass index and ethnicity are associated with significant fibrosis. Effective noninvasive strategies are urgently needed to differentiate simple steatosis from progressive forms.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

A review of non-alcoholic fatty liver disease in non-obese and lean individuals

Mitra Ahadi et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common cause of liver disorders associated with type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, and obesity. The pathogenesis of NAFLD in non-obese patients involves genetic predispositions and dietary factors, particularly high fructose consumption. Treatment typically involves lifestyle changes such as dietary modification, weight loss, and increased physical activity.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

Sylwia Ziolkowska et al.

Summary: NAFLD is a common chronic liver disorder which is often associated with type 2 diabetes and obesity. Metabolic syndrome is a key factor in the development of NAFLD, as it includes a range of conditions such as abdominal obesity, elevated blood triacylglycerol level, reduced high-density lipoprotein cholesterol level, increased blood pressure, and high fasting glucose.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Gastroenterology & Hepatology

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

Mohammed Eslam et al.

Summary: The proposed framework for pediatric fatty liver diseases includes an age-appropriate MAFLD definition based on sex and age percentiles, recognizing the possibility of other coexisting systemic fatty liver diseases in children. This new MAFLD diagnostic criteria provide pediatricians with a conceptual scaffold for disease diagnosis, risk stratification, and improved clinical and multidisciplinary care, aligning with a definition that is valid across the lifespan.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem

Sebastien Le Garf et al.

Summary: MAFLD, formerly known as NAFLD, is a significant global cause of chronic liver disease and has become the main form of liver disease in children and adolescents, highlighting the crucial importance of early diagnosis.

BIOMEDICINES (2021)

Article Pediatrics

Alternative Etiologies of Liver Disease in Children With Suspected NAFLD

Toshifumi Yodoshi et al.

Summary: In a cohort of children with overweight and obesity undergoing evaluation for NAFLD, most did not have alternative causes of liver disease and none were diagnosed with AIH.

PEDIATRICS (2021)

Article Medicine, General & Internal

Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study

Xin Zhang et al.

Summary: The prevalence of NAFLD/NASH among children, adolescents, and young adults has been increasing globally, with the greatest increase observed in North Africa and the Middle East. Despite variations in regions and genders, there has been a consistent rise in both the number of cases and prevalence of NAFLD/NASH over the past three decades. This trend may lead to a higher burden of chronic liver disease in the near future, highlighting the importance of developing public health policies to address this issue.

BMJ OPEN (2021)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping

Zhipeng Liu et al.

JOURNAL OF HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)

Zahra Safari et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Article Gastroenterology & Hepatology

Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States

Praveen Kumar Conjeevaram Selvakumar et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease in Children

Jake P. Mann et al.

SEMINARS IN LIVER DISEASE (2018)

Review Gastroenterology & Hepatology

Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model

Yan-Lan Fang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver

Alexandra Feldman et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Biochemistry & Molecular Biology

TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD

Giovanni Musso et al.

JOURNAL OF LIPID RESEARCH (2017)

Article Gastroenterology & Hepatology

PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

Luca Valenti et al.

LIVER INTERNATIONAL (2016)

Article Gastroenterology & Hepatology

Association of INSIG2 rs9308762 With ALT Level Independent of BMI

Li Guan et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)